Changing the way we treat multiple myeloma based on biological markers in 2016
What are the challenges of allogeneic stem cell transplant in myeloma?
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
CLL update from ICML17: Current treatment and future directions for patients
Relapse in DLBCL - addressing the unmet need with brentuximab vedotin